Regeneron Pharmaceuticals, Inc. (VIE:REGN)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	65,935	67,449	74,026	84,502	72,102	58,059
Market Cap Growth	-7.47%	-8.88%	-12.40%	17.20%	24.19%	39.28%
Enterprise Value	52,256	53,802	58,974	72,751	62,474	50,391
Last Close Price	644.00	662.80	671.66	796.56	669.07	569.63
PE Ratio	17.18	17.58	17.37	23.63	17.76	8.18
PS Ratio	5.40	5.52	5.40	7.12	6.33	4.11
PB Ratio	2.48	2.53	2.61	3.60	3.40	3.52
P/TBV Ratio	2.58	2.64	2.72	3.75	3.54	3.52
P/FCF Ratio	-	-	20.91	24.10	17.42	10.11
P/OCF Ratio	-	-	17.34	20.33	15.37	9.32
EV/Sales Ratio	4.30	4.40	4.30	6.13	5.49	3.57
EV/EBITDA Ratio	14.49	14.83	13.19	17.28	12.51	6.18
EV/EBIT Ratio	16.56	16.95	14.73	19.00	13.37	6.37
EV/FCF Ratio	-	-	16.66	20.75	15.09	8.78
Debt / Equity Ratio	0.09	0.09	0.10	0.11	0.12	0.14
Debt / EBITDA Ratio	0.64	0.64	0.63	0.60	0.52	0.29
Debt / FCF Ratio	-	-	0.80	0.72	0.63	0.41
Asset Turnover	0.37	0.37	0.40	0.42	0.45	0.76
Inventory Turnover	2.53	2.53	2.51	2.51	2.37	2.74
Quick Ratio	4.22	4.22	3.86	4.82	4.16	2.98
Current Ratio	4.77	4.77	4.73	5.69	5.06	3.56
Return on Equity (ROE)	14.87%	14.87%	15.95%	16.26%	20.94%	54.21%
Return on Assets (ROA)	5.95%	5.95%	7.31%	8.49%	11.42%	26.39%
Return on Invested Capital (ROIC)	15.93%	16.73%	18.58%	22.38%	26.65%	60.13%
Return on Capital Employed (ROCE)	10.70%	10.70%	12.30%	14.30%	19.20%	41.80%
Earnings Yield	5.82%	5.69%	5.76%	4.23%	5.63%	12.23%
FCF Yield	-	-	4.78%	4.15%	5.74%	9.89%
Dividend Yield	0.49%	0.45%	-	-	-	-
Buyback Yield / Dilution	5.65%	5.65%	-1.23%	-0.18%	-1.16%	2.52%
Total Shareholder Return	6.14%	6.10%	-1.23%	-0.18%	-1.16%	2.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.